Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-08-16 Sale |
2023-08-18 4:03 pm |
Foghorn Therapeutics Inc. | FHTX | Agresta Samuel Chief Medical Officer |
311,297 | $8.25 | $2,568,200 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-27 Option Award |
2025-01-29 8:33 pm |
N/A 2035-01-26 |
OnKure Therapeutics Inc. | OKUR | Agresta Samuel Chief Medical Officer |
45,000 | $0 | 45,000 (Direct) |
View |
| 2024-10-04 Option Award |
2024-10-08 7:20 pm |
N/A 2034-02-05 |
OnKure Therapeutics Inc. | OKUR | Agresta Samuel Chief Medical Officer |
149,984 | $0 | 149,984 (Direct) |
View |
| 2023-08-16 Exercise |
2023-08-18 4:03 pm |
N/A 2029-09-16 |
Foghorn Therapeutics Inc. | FHTX | Agresta Samuel Chief Medical Officer |
311,297 | $0 | 0 (Direct) |
View |
| 2023-08-16 Exercise |
2023-08-18 4:03 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | Agresta Samuel Chief Medical Officer |
311,297 | $3.72 | 0 (Direct) |
View |
| 2023-01-26 Option Award |
2023-01-30 5:04 pm |
N/A 2033-01-25 |
Foghorn Therapeutics Inc. | FHTX | Agresta Samuel Chief Medical Officer |
60,000 | $0 | 60,000 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-16 8:42 pm |
N/A 2032-06-16 |
INFINITY PHARMACEUTICALS INC. | INFI | Agresta Samuel Director |
45,000 | $0 | 45,000 (Direct) |
View |
| 2022-01-26 Option Award |
2022-01-28 4:27 pm |
N/A 2032-01-25 |
Foghorn Therapeutics Inc. | FHTX | Agresta Samuel Chief Medical Officer |
125,000 | $0 | 125,000 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-11 4:16 pm |
N/A 2031-06-09 |
INFINITY PHARMACEUTICALS INC. | INFI | Agresta Samuel Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2021-01-28 Option Award |
2021-02-01 9:26 pm |
N/A 2031-01-27 |
Foghorn Therapeutics Inc. | FHTX | Agresta Samuel Chief Medical Officer |
100,000 | $0 | 100,000 (Direct) |
View |
Ownership |
2020-10-22 8:50 pm |
N/A 2029-09-16 |
Foghorn Therapeutics Inc. | FHTX | Agresta Samuel Chief Medical Officer |
0 | $0 | 403,188 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-18 08:30 am |
N/A 2030-06-16 |
INFINITY PHARMACEUTICALS INC. | INFI | Agresta Samuel Director |
30,000 | $0 | 30,000 (Direct) |
View |